STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices

STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices

You’re reading the web edition of STAT’s Health Tech newsletter Adobe Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer telehealth. Confidential tips can be sent on Signal at palmer.01. You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Hello, health tech readers! Next week, the newsletter is going on its annual summer hiatus — we’ll see you back on the 25th. Today, a deep dive into Commure, a company promising to automate the business of health care with artificial intelligence — and all the levers it’s pulling to make that happen. Let’s get right into it. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Health Tech Correspondent Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer telehealth. Confidential tips can be sent on Signal at palmer.01.

Original Source

Read the full article at Statnews →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.